| Kidney Stones and Urolithiasis Treatments | Lifetime | 37 | TH 1 | 99.33 |
| Metabolomics and Mass Spectrometry Studies | Lifetime | 403 | TH 1 | 97.87 |
| Advanced Proteomics Techniques and Applications | Lifetime | 186 | TH 1 | 97.88 |
| Extracellular vesicles in disease | Lifetime | 461 | TH 1 | 96.42 |
| Paleopathology and ancient diseases | Lifetime | 61 | TH 2 | 96.61 |
| Pediatric Urology and Nephrology Studies | Lifetime | 481 | TH 1 | 97.31 |
| Chronic Kidney Disease and Diabetes | Lifetime | 555 | TH 1 | 97.04 |
| Porphyrin Metabolism and Disorders | Lifetime | 349 | TH 1 | 95.13 |
| Advanced Glycation End Products research | Lifetime | 581 | TH 3 | 93.69 |
| Connexins and lens biology | Lifetime | 591 | TH 1 | 93.89 |
| Advanced Biosensing Techniques and Applications | Lifetime | 762 | TH 4 | 92.06 |
| Hemostasis and retained surgical items | Lifetime | 272 | TH 2 | 90.45 |
| Tea Polyphenols and Effects | Lifetime | 829 | TH 4 | 90.43 |
| Biomedical Research and Pathophysiology | Lifetime | 563 | TH 1 | 89.44 |
| Therapeutic Uses of Natural Elements | Lifetime | 389 | TH 2 | 88.36 |
| Leptospirosis research and findings | Lifetime | 510 | TH 18 | 87.65 |
| Coffee research and impacts | Lifetime | 810 | TH 4 | 84.68 |
| Burkholderia infections and melioidosis | Lifetime | 897 | TH 81 | 67.76 |
| Kidney Stones and Urolithiasis Treatments | 2021-2025 | 12 | TH 1 | 99.26 |
| Paleopathology and ancient diseases | 2021-2025 | 3 | TH 1 | 97.67 |
| Pediatric Urology and Nephrology Studies | 2021-2025 | 47 | TH 1 | 97.36 |
| Biomedical Research and Pathophysiology | 2021-2025 | 16 | TH 1 | 95.07 |
| Extracellular vesicles in disease | 2021-2025 | 346 | TH 1 | 94.79 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 183 | TH 1 | 95.66 |
| Porphyrin Metabolism and Disorders | 2021-2025 | 23 | TH 1 | 92.42 |
| Connexins and lens biology | 2021-2025 | 86 | TH 2 | 87.34 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 73 | TH 1 | 83.94 |
| Chromatin Remodeling and Cancer | 2021-2025 | 254 | TH 3 | 76.52 |
| S100 Proteins and Annexins | 2021-2025 | 705 | TH 1 | 65.31 |
| Advanced Glycation End Products research | 2021-2025 | 767 | TH 6 | 62.71 |
| Hemostasis and retained surgical items | 2021-2025 | 518 | TH 3 | 46.68 |
